Advancing the Quality of Cancer Care through Behavioral Economics and Implementation Science

通过行为经济学和实施科学提高癌症护理质量

• 批准号: 10419373
• 负责人: Rinad Sary Beidas
• 金额: $ 7.5万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-01 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10419373
• 关键词: Address; American; Cancer Control; Cancer Patient; Coupled; Data Pooling; Development; Ecosystem; Ensure; Environment; Evidence based practice; Goals; Healthcare; Hospitals; Individual; Knowledge; Laboratories; Link; Malignant Neoplasms; Measurement; Measures; Medicine; Methodology; Methods; National Cancer Institute; Oncologist; Patients; Pennsylvania; Pilot Projects; Principal Investigator; Research; Research Personnel; Resources; Science; Testing; TimeLine; Tobacco Use Cessation; Underserved Population; Universities; Variant; behavioral economics; cancer care; care delivery; care outcomes; clinical research site; comparative; effectiveness outcome; health equity; implementation outcomes; implementation science; implementation strategy; improved; improved outcome; innovation; insight; lens; multidisciplinary; novel; programs; research to practice; shift work; uptake

The grand challenge addressed by the Penn Implementation Science Center in Cancer Control (Penn ISC3) is to apply insights from behavioral economics to accelerate the pace at which evidence-based practices for cancer care are deployed to improve outcomes and equity for individuals with cancer. Penn offers a unique environment in which to conduct this paradigm- shifting work, given our expertise in implementation science, behavioral economics, and innovative cancer care delivery. The complementary and multi-disciplinary expertise of the three MPIs (Beidas, Bekelman, Schnoll), coupled with existing Penn resources represent a unique opportunity to advance the quality of cancer care. Our partnership with Columbia University and Dr. Rachel Shelton will allow us to address critical questions regarding health equity. The Administrative Core will ensure that the activities of Penn ISC3 are coordinated, synergistic, and congruent with timelines. The Implementation Laboratory represents a diverse ecosystem that includes five hospitals and linked clinical sites, with over 200 oncologists that serve over 15,000 unique new patients annually. Our Research Program will oversee the development and testing of implementation strategies that target patients and clinicians within our Implementation Lab and are centered on the idea of `nudging' for optimal implementation and effectiveness outcomes. The Research Program includes investigators with expertise in implementation science, behavioral economics, cancer care delivery research, healthcare innovation, health equity, measurement, and mixed methods. In the first two years, we propose two Signature Pilot Projects and three Methods Projects. Signature Pilot Project 1 tests patient- and clinician-directed implementation strategies to increase referral to tobacco cessation programs among cancer patients. Signature Pilot Project 2 tests patient- and clinician-directed implementation strategies to increase serious illness conversations. Common methods and measures are linked to allow for pooling of data and to accomplish our objectives of testing multi-level implementation strategies and mechanisms across contexts. Three methods projects, in support of the Projects, will advance the science of implementation methods. Methods Project 1 will support the application of rapid cycle approaches; Methods Project 2 will use qualitative comparative analysis to characterize multilevel contextual variation. Methods Project 3 will provide methodological and theoretical support in incorporating a health equity lens to the methods, measures, frameworks, and strategies ap-plied across the SPPs. The Penn ISC3 has the potential to identify novel, disseminable, and scalable ways to advance the quality and equity of cancer care.

宾州癌症控制实施科学中心（Penn Implementation Science Center in Cancer Control） (Penn ISC 3）是应用行为经济学的见解来加快 部署癌症护理的循证实践，以改善结果和公平性， 患有癌症的人。宾夕法尼亚大学提供了一个独特的环境来进行这种范式- 转移工作，考虑到我们在实施科学，行为经济学， 创新的癌症护理服务。三家公司的互补性和多学科专长 MPI（Beidas，Bekelman，Schnoll），加上现有的宾夕法尼亚资源，代表了一个独特的 提高癌症护理质量的机会。我们与哥伦比亚大学的合作关系， 博士雷切尔谢尔顿将允许我们解决有关健康公平的关键问题。的 行政核心将确保宾夕法尼亚州ISC 3的活动协调，协同， 与时间线一致实施实验室代表了一个多样化的生态系统， 包括五家医院和相关的临床站点，拥有200多名肿瘤学家，为15，000多名 每年都有新的病人。我们的研究计划将监督开发和测试 我们实施实验室内针对患者和临床医生的实施策略， 以“轻推”的思想为中心，以实现最佳执行和有效成果。的 研究计划包括具有实施科学，行为科学和生物学专业知识的研究人员。 经济学，癌症护理提供研究，医疗创新，健康公平，测量， 混合方法。在头两年，我们提出了两个签名试点项目和三个 方法项目。签名试点项目1测试患者和临床医生指导的实施 增加癌症患者戒烟计划的转诊策略。签名 试点项目2测试患者和临床医生指导的实施策略，以增加严重的 疾病对话共同的方法和措施相互联系，以便汇集数据， 实现我们测试多层次实施战略和机制的目标 跨语境。三个方法项目，以支持项目，将推进科学的， 实施方法。方法项目1将支持快速循环的应用 方法项目2将使用定性比较分析来表征多层次 语境变异方法项目3将提供方法和理论支持， 将健康公平透镜纳入所应用的方法、措施、框架和战略 在SPPs中。Penn ISC 3有潜力识别新的、可传播的和可扩展的 提高癌症护理质量和公平性的方法。